Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Jensen-Group NV | JEN | Nov 20, 2024 | 42.50 | 0.00 |
KBC Ancora SA | KBCA | Nov 20, 2024 | 47.50 | -0.63 |
KBC Groupe NV | KBC | Nov 20, 2024 | 69.52 | -1.36 |
Keyware Technologies NV | KEYW | Nov 20, 2024 | 0.79 | 0.00 |
KIADIS | KDS | Nov 20, 2024 | 5.46 | 0.00 |
Kinepolis Group NV | KIN | Nov 20, 2024 | 37.65 | -0.26 |
KKO International SA | ALKKO | Nov 20, 2024 | 0.09 | +3.39 |
Leasinvest Real Estate SCA | LEAS | Nov 20, 2024 | 72.60 | 0.00 |
Lotus Bakeries NV | LOTB | Nov 20, 2024 | 11 560.00 | +1.23 |
Lux Airport Cer | LUXA | Nov 20, 2024 | 6.22 | 0.00 |
Marathon Oil | MROIL | Nov 20, 2024 | 15.62 | 0.00 |
Mazaro N.V. | MLMAZ | Nov 20, 2024 | 3.00 | 0.00 |
MDxHealth SA | MDXH | Nov 20, 2024 | 3.02 | 0.00 |
Melexis NV | MELE | Nov 20, 2024 | 54.65 | +0.28 |
Microsoft | MSF | Nov 20, 2024 | 319.20 | 0.00 |
Miko N.V. | MIKO | Nov 20, 2024 | 51.40 | -1.15 |
Mithra Pharmaceuticals S.A. | MITRA | Nov 20, 2024 | 0.22 | 0.00 |
Montea NV | MONT | Nov 20, 2024 | 63.90 | -1.08 |
Mopoli Parts de Fondateur. | MOPF | Nov 20, 2024 | 7 850.00 | 0.00 |
Moury Construct SA | MOUR | Nov 20, 2024 | 535.00 | +0.94 |
Muenchener Rueckversicherungs-Gesellschaft AG | MEURV | Nov 20, 2024 | 379.40 | 0.00 |
Neufcour (Compagnie Financiere | NEU | Nov 20, 2024 | 13.30 | 0.00 |
Neufcour (Compagnie Financiere de) SA | MLNEU | Nov 20, 2024 | 7.30 | 0.00 |
Newtree SA | NEWT | Nov 20, 2024 | 2.26 | 0.00 |
Nextensa SA | NEXTA | Nov 20, 2024 | 41.15 | +1.23 |
NV Bekaert SA. | BEKB | Nov 20, 2024 | 32.06 | +1.07 |
Nyrstar NV | NYR | Nov 20, 2024 | 0.08 | +1.30 |
Nyxoah SA | NYXH | Nov 20, 2024 | 8.00 | +2.30 |
Occidental Petroleum | OCPET | Nov 20, 2024 | 58.10 | 0.00 |
ONTEX GROUP NV EO -,01 | ONTEX | Nov 20, 2024 | 7.48 | +0.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.